Innate immunity in type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 824-829

  Zipris, Danny ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

BBDR; Inflammation; Innate immunity; Kilham rat virus; LEW1.WR1; Type 1 diabetes

Indexed keywords

ALPHA INTEGRIN; CHEMOKINE RECEPTOR CCR5; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DEXAMETHASONE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 3; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; TOLL LIKE RECEPTOR AGONIST; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BODY WEIGHT; CYTOKINE PRODUCTION; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LATENT RAT PARVOVIRUS; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; VIRUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION PROFILING; IMMUNITY, INNATE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; RATS; RATS, INBRED BB; RATS, INBRED LEW;

EID: 80855147947     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1256     Document Type: Article

References (43)

1. Eisenbarth GS. Update in type 1 diabetes. J Clin Endocrinol Metab 2007; 92: 2403-2407.
2. Kyvik KO, Nystrom L, Gorus F, et al. The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 2004; 47: 377-384.
3. Srikanta S, Ganda OP, Jackson RA, et al. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med 1983; 99: 320-326.
4. Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev 2005; 204: 232-249.
5. Dotta F, Censini S, van Halteren AGS, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007; 104: 5115-5120.
6. Dotta F, Galleri L, Sebastiani G, Vendrame F. Virus infections: lessons from pancreas histology. Curr Diab Rep 2010; 10: 357-361.
7. Banatvala JE, Bryant J, Schernthaner G, et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1985; 1: 1409-1412.
8. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet 1983; 1: 1397-1399.
9. King ML, Bidwell D, Voller A, Bryant J, Banatvala JE. Role of Coxsackie B viruses in insulin-dependent diabetes mellitus. Lancet 1983; 2: 915-916.
10. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses-some recent developments. Diabetologia 1993; 36: 687-695.
11. Ginsberg-Fellner F, Witt ME, Yagihashi S, et al. Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 1984; 27(Suppl): 87-89.
12. Gamble DR. Relation of antecedent illness to development of diabetes in children. Br Med J 1980; 281: 99-101.
13. Hiltunen M, Hyoty H, Karjalainen J, et al. Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. The Childhood Diabetes in Finland Study Group. Diabetologia 1995; 38: 705-710.
14. Chikazawa K, Okusa H, Minakami H, Kimura K, Araki S, Tamada T. Acute onset of insulin-dependent diabetes mellitus caused by Epstein-Barr virus infection. Nippon Sanka Fujinka Gakkai Zasshi 1985; 37: 453-456.
15. Jaeckel E, Manns M, von Herrath M. Viruses and diabetes. Ann N Y Acad Sci 2002; 958: 7-25.
16. Mordes JP, Guberski DL, Leif JH, et al. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 2005; 54: 2727-2733.
17. Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA. Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 1996; 45: 557-562.
18. Ellerman KE, Like AA. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 2000; 43: 890-898.
19. Londono P, Komura A, Hara N, Zipris D. Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetes. Clin Immunol 2010; 135: 401-411.
20. Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J 2004; 45: 278-291.
21. Brown DD, Salzman LA. Sequence homology between the structural proteins of Kilham rat virus. J Virol 1984; 49: 1018-1020.
22. Jacoby RO, Ball-Goodrich LJ, Besselsen DG, McKisic MD, Riley LK, Smith AL. Rodent parvovirus infections. Lab Anim Sci 1996; 46: 370-380.
23. Cherry JD. Parvovirus infections in children and adults. Adv Pediatr 1999; 46: 245-269.
24. Bultmann BD, Klingel K, Sotlar K, et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003; 34: 92-95.
25. Schowengerdt KO, Ni J, Denfield SW, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 1997; 96: 3549-3554.
26. Tsay GJ, Zouali M. Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity. Biochem Pharmacol 2006; 72: 1453-1459.
27. Nesher G, Rubinow A, Sonnenblick M. Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study. Clin Exp Rheumatol 1997; 15: 303-306.
28. Barton GM, Medzhitov R. Toll-like receptors and their ligands. Curr Top Microbiol Immunol 2002; 270: 81-92.
29. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med 2002; 30: S1-S11.
30. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343: 338-344.
31. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
32. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
33. Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005; 174: 131-142.
34. Zipris D, Lien E, Nair A, et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J Immunol 2007; 178: 693-701.
35. Wolter TR, Wong R, Sarkar SA, Zipris D. DNA microarray analysis for the identification of innate immune pathways implicated in virus-induced autoimmune diabetes. Clin Immunol 2009; 132: 103-115.
36. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4 + CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-1036.
37. Lien E, Zipris D. The role of toll-like receptor pathways in the mechanism of type 1 diabetes. Curr Mol Med 2009; 9: 52-68.
38. Wilckens T, De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997; 18: 418-424.
39. Besedovsky HO, del Rey A. Regulating inflammation by glucocorticoids. Nat Immunol 2006; 7: 537.
40. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of IkappaB synthesis. Science 1995; 270: 286-290.
41. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005; 353: 1711-1723.
42. Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603-616.
43. Wust S, van den Brandt J, Tischner D, et al. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J Immunol 2008; 180: 8434-8443.